Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer
出版年份 2023 全文链接
标题
Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer
作者
关键词
-
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-29
DOI
10.1007/s00280-023-04607-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping
- (2022) Cassandra White et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma
- (2022) Satoru Matsuda et al. ANNALS OF SURGERY
- Bifunctional effect of the inflammatory cytokine tumor necrosis factor α on megakaryopoiesis and platelet production
- (2022) Tiantian Chu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy
- (2021) Kazuma Fujita et al. Esophagus
- Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects
- (2020) Jiaming Li et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy
- (2020) Hisanaga Nomura et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Functional annotation of noncoding causal variants in autoimmune diseases
- (2019) Ali Yousefian-Jazi et al. GENOMICS
- Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinoma
- (2018) Yasuhiro Arakawa et al. Oncology Letters
- Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients
- (2018) Sander Bins et al. CLINICAL PHARMACOKINETICS
- The role of pharmacogenetics in capecitabine efficacy and toxicity
- (2016) S.W. Lam et al. CANCER TREATMENT REVIEWS
- IL-6 and MCP-1 genetic polymorphisms are predictive of decreased platelet counts caused by chemoradiotherapy in esophageal cancer
- (2016) Kazuma Fujita et al. Esophagus
- Genetic Polymorphisms in SLC23A2 as Predictive Biomarkers of Severe Acute Toxicities after Treatment with a Definitive 5-Fluorouracil/Cisplatin-Based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
- (2014) Tetsuya Minegaki et al. International Journal of Medical Sciences
- Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
- (2013) Hiroki Hara et al. CANCER SCIENCE
- Epidemiology of Esophageal Cancer in Japan and China
- (2013) Yingsong Lin et al. JOURNAL OF EPIDEMIOLOGY
- Effects of 5-fluorouracil chemotherapy on fatigue: Role of MCP-1
- (2012) S.E. Mahoney et al. BRAIN BEHAVIOR AND IMMUNITY
- Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin
- (2012) TETSUYA MINEGAKI et al. Oncology Letters
- Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function
- (2010) S Laechelt et al. PHARMACOGENOMICS JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started